Tenomix

Robotics & Autonomous SystemsAILondon, ON

London, Ontario company building the Lymphonator, an automated benchtop robotic scanning device that combines ultrasound imaging, robotics and AI to find lymph nodes in excised cancer tissue for pathology labs.

The Toronto skyline and the CN Tower at sunset, seen across Lake Ontario.

Canadian innovation builds a brighter tomorrow.

About

Company site: tenomix.com

London, Ontario company building the Lymphonator, an automated benchtop robotic scanning device that combines ultrasound imaging, robotics and AI to find lymph nodes in excised cancer tissue for pathology labs.

  • Federal corporation Tenomix Inc. (Juri ID 1320607-6), status Active, registered office in London, Ontario, incorporated 2021-07-22. ised-isde.canada.ca

  • Western University spin-off based at BioNext; raised over $2M in seed funding announced 11 March 2024 from FACIT, the Ontario Centre for Innovation's Life Sciences fund and angels. news.westernu.ca

  • Selected for the Government of Canada's Innovative Solutions Canada (ISC) Testing Stream, per its own newsroom (November 2025). tenomix.com

  • Collaborated with the Mayo Clinic on lymph-node research published in Frontiers in Medicine, per its own newsroom (September 2025). tenomix.com

Products & Services

Company site: tenomix.com

Products Tenomix publishes on its own site. Each card links to the page it was taken from.

The Lymphonator

Robotic pathology automation

An automated, bench-top robotic scanning device using ultrasound imaging, robotics, AI and custom tissue-interfacing tools to autonomously scan and mark lymph nodes in excised cancer tissue, aimed at making lymph-node search in colorectal cancer tissue less labour-intensive and more reliable.

Source

Funding & Investors

Announced rounds only, newest first. Undisclosed amounts are shown as undisclosed.

  1. Seed

    Mar 11, 2024

    Investors: FACIT, Ontario Centre for Innovation, Phoenix Fire Fund (Archangel Network)

Latest: Seed · Mar 11, 2024

Partnerships

Publicly announced partnerships.

Mayo Clinic

Research collaboration on lymph-node retrieval published in Frontiers in Medicine, per Tenomix's newsroom, September 2025.

Government & Grants

Government support actually received. Unpublished amounts are left out.

  1. Innovative Solutions Canada — Testing Stream (selected participant)

  2. Industrial Research Assistance Program – Youth Employment Program, National Research Council Canada

  3. CanExport SME, National Research Council Canada

  4. CanExport Innovation, National Research Council Canada

  5. Industrial Research Assistance Program – Contributions to Firms, National Research Council Canada — contribution

  6. Industrial Research Assistance Program – Youth Employment Program, National Research Council Canada

  7. Industrial Research Assistance Program – Contributions to Firms, National Research Council Canada — contribution

Recent News

  1. Mar 11, 2024Funding

    Western spin-off secures over $2M in seed funding for cancer care robotics system

    Tenomix raised more than $2 million in seed funding from FACIT, the Ontario Centre for Innovation's Life Sciences Innovation Fund, and the Phoenix Fire Fund, to develop its Lymphonator robotic lymph-node retrieval system.

People

Sourced from the company's own pages or announcements.

Saumik Biswas

President and Chief Executive Officer

Eveline Pasman

Chief Operating Officer and Co-Founder

Michael Lavdas

Chief Technology Officer

Technology Focus

Company site: tenomix.com

Terms the company uses about its own work.

Robotic ultrasoundLymph node retrievalPathology automation

Similar Companies

Other companies in Robotics & Autonomous Systems.

Join Canada’s innovation community.

Discover companies, track funding, explore career opportunities and stay informed about Canada’s growing tech ecosystem.

624
Verified Companies
45
Funding Opportunities
19
Sectors
A stronger Canada together